Author

Suzanne van der Pol

Amsterdam Neuroscience

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Andy ChevignéiD· 1 shared Desislava N. NeshevaiD· 1 shared Henry F. VischeriD· 1 shared Iwan J. P. de EschiD· 1 shared Justyna M. AdamskaiD· 1 shared Maikel WijtmansiD· 1 shared Martyna SzpakowskaiD· 1 shared Maurice C. M. L. BuzinkiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Andy ChevignéORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Inhibition of constitutive activity of the atypical chemokine receptor ACKR3 by the small-molecule inverse agonist VUF16840

Reggie Bosma, Desislava N. Nesheva, Merel Rijnsburger, Rick Riemens, Justyna M. Adamska, Max Meyrath, Simon Mobach, Maurice C. M. L. Buzink, Suzanne van der Pol, Iwan J. P. de Esch, Martyna Szpakowska, Maikel Wijtmans, Andy Chevigné, Henry F. Vischer, Rob Leurs

This study characterizes VUF16840 as a selective inverse agonist of ACKR3 that inhibits constitutive and chemokine-induced signaling by stabilizing the inactive conformation of the receptor.

Molecular Pharmacology · Oct 26, 2025Peer-reviewedPharmacology & Toxicology